Get startedLog in
    Picture of Biosenic SA logo

    BIOS — Biosenic SA News Story

    0.000.00%
    be flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapValue Trap
    All News

    Brief: Biosenic ALLOB PHASE IIB Topline Results Foreseen In Q2 2023

    Picture of Biosenic SA logoBiosenic SA
    27/04/2023 06:23
    April 27 (Reuters) - Bone Therapeutics SA  BIOS.BR :
    * REG-BIOSENIC ANNOUNCES 2022 FULL YEAR RESULTS
    * BONE THERAPEUTICS SA - ALLOB PHASE IIB TOPLINE RESULTS
FORESEEN
IN Q2 2023
    * BONE THERAPEUTICS SA - ATO PHASE III TO BE LAUNCHED IN
2023
    * BONE THERAPEUTICS SA - ONGOING DISCUSSIONS FOR KEY
PARTNERSHIPS
WITH LEAD CLINICAL ASSETS

Source text for Eikon:  ID:nGNE9FGGrP 
Further company coverage:  BIOS.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Biosenic SA

    See all news